HRR testing and PARPi utilization among patients with metastatic castration resistant prostate cancer treated in the real-world setting.

被引：0
|
作者：
Vasudevan, Anupama [1 ]
Katzen, Harvey I. [1 ]
Gart, Mike [1 ]
Blanc, Simon [1 ]
机构：
[1] Integra Connect PrecisionQ, W Palm Beach, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.91
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
91
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] Real-world biomarker testing patterns in metastatic castration-resistant prostate cancer patients
    Blanc, Simon
    Adeboyeje, Gboyega
    Lee, Liam
    Gart, Mike
    Saunders, William
    Wang, Brandon
    Dave, Poras
    English, Sandy
    Varughese, Prateesh
    Sillah, Arthur
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [2] Real-world genetic testing patterns in metastatic castration-resistant prostate cancer
    Shore, Neal
    Ionescu-Ittu, Raluca
    Yang, Lingfeng
    Laliberte, Francois
    Mahendran, Malena
    Lejeune, Dominique
    Yu, Louise
    Burgents, Joseph
    Duh, Mei Sheng
    Ghate, Sameer R.
    [J]. FUTURE ONCOLOGY, 2021, 17 (22) : 2907 - 2921
  • [3] Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Shore, N.
    Ionescu-Ittu, R.
    Yang, L.
    Laliberte, F.
    Payne, S.
    Gayle, A.
    Amin, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S526 - S527
  • [4] Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer
    Hommerding, Moritz
    Hommerding, Oliver
    Bernhardt, Marit
    Kreft, Tobias
    Sanders, Christine
    Tischler, Verena
    Basitta, Patrick
    Pelusi, Natalie
    Wulf, Anna-Lena
    Ohlmann, Carsten-Henning
    Ellinger, Joerg
    Ritter, Manuel
    Kristiansen, Glen
    [J]. WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [5] Real-world data on metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: A regional experience
    Raju, R.
    Sahu, A.
    Klevansky, M.
    Torres, J.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1332 - S1332
  • [6] Real-world treatment landscape in advanced metastatic castration resistant prostate cancer
    Sacchi, Elizabeth
    Singhal, Hari
    Zamalloa, Jose
    Sanchez, Beatriz Lopez
    Zhang, Ke
    Parihar, Harish
    Greshock, Joel
    Max, Steven I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Real-world treatment patterns among patients with metastatic castration-resistant prostate cancer (mCRPC) in the US.
    Malangone-Monaco, Elisabetta
    Li, Weiyan
    Noxon, Virginia
    Jiang, Shan
    Amin, Suvina
    Ghate, Sameer
    Swami, Umang
    Agarwali, Neeraj
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States
    Schiff, Howard I.
    [J]. JOURNAL OF UROLOGY, 2022, 207 (04): : 939 - 939
  • [9] Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States
    Ryan, Charles J.
    Ke, Xuehua
    Lafeuille, Marie-Helene
    Romdhani, Hela
    Kinkead, Frederic
    Lefebvre, Patrick
    Petrilla, Allison
    Pulungan, Zul
    Kim, Seung
    D'Andrea, Denise M.
    Francis, Peter
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2021, 206 (06): : 1420 - 1429
  • [10] Real-world effectiveness of PARP inhibitors (PARPi) in metastatic castration-resistant prostate cancer (mCRPC) by genomic homologous recombination repair (HRR) alterations and homologous recombination deficiency signature (HRDsig).
    Triner, Daniel
    Graf, Ryon
    Gjoerup, Ole
    Tukachinsky, Hanna
    Ross, Jeffrey S.
    Cheng, Heather H.
    Pritchard, Colin C.
    Zurita, Amado J.
    Mateo, Joaquin
    Cieslik, Marcin
    Morgan, Todd Matthew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 186 - 186
12345